Pilot Study for First Clinical Use of sc2Wear Furosemide Combination Product

Summary

The proposed pilot study aims to gain experience with the first clinical use of the to-be marketed drug-device combination product, the sc2Wear Furosemide Combination Product and to assess methods and procedures for evaluation of product performance. The objectives of this study are: * To gain first in man experience of a novel drug-device combination product * To evaluate the suitability of the methods and procedures for evaluating of the performance of the sc2Wear Pump

Timeline

Start

2016-07

Primary completion

2016-08

Completion

2016-08

Drugs

Indications